Status:
COMPLETED
Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma
Lead Sponsor:
Dr.dr.Irma Bernadette, SpKK (K)
Conditions:
Melasma
Hyperthyroidism
Eligibility:
FEMALE
18-60 years
Phase:
PHASE1
Brief Summary
Study's objectives are to determine proportion of melasma cases in hyperthyroid patients and to compare severity of melasma before and after medications of three months hyperthyroid therapy using modi...
Detailed Description
Melasma is an acquired and chronic disorder of hyperpigmentation characterized by symmetrical hypermelanoses of the face. The exact pathogenesis of melasma is still unknown. Several hormones are thoug...
Eligibility Criteria
Inclusion
- Female with age range of 18 to 60 years old
- Newly diagnosed with hyperthyroid on a laboratory basis
- Diagnosed with melasma by dermatologist
Exclusion
- Pregnant or breastfeeding
- Using hormonal contraception or history of using hormonal contraception within 1 year
- On anti-seizure therapy or hormone replacement therapy
- History of drug use that can affect the thyroid
- History of using topical hydroquinone in the last 3 months and / or using a topical steroid and / or an vitamin A analog and / or received chemical peeling in the last 1 month
- History of laser therapy and / or mechanical abrasion therapy in the past 9 months
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04346901
Start Date
August 1 2019
End Date
February 15 2020
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
dr. Cipto Mangunkusumo Hospital
Jakarta, Jakarta Pusat, Indonesia, 10430